LIVE UPDATES
A pioneering breast cancer research study named for the late Girls Aloud singer Sarah Harding is already identifying young women who are more likely to develop the disease.
The BCAN-RAY (Breast Cancer Risk Assessment in Young Women) was created one year ago in the singer's name after she died from cancer in 2021 at the age of 39.
While undergoing treatment, the celebrity expressed her desire for deeper research into why young women are being diagnosed with the disease despite having no family history of it.
One of the singer's ultimate aspirations was to discover ways to detect the condition early when it is simpler to treat.
The BCAN-RAY is one of the only projects in the world trying to identify which women in their 30s are most at risk.
About 2,300 women under 40 are diagnosed with the disease each year in the UK, according to Breast Cancer Now.
The two-year study is using money from Cancer Research UK, the Christie Charity, and the Sarah Harding Breast Cancer Appeal - backed by her family and former bandmates.
